Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy

UNC Libraries(2020)10.17615/xcnw-dm02Source: DataRank Database

Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (43)IDs (PubMed, OpenAlex)SDGs (5)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Hide, Winston,Daniel R. Kuritzkes ORCID,Alyssa Jocson Porter,Michael C. Zody ORCID,Saran Vardhanabhuti ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4299881738

National Institutes of Health

Grant: 5U01AI068634-03

Statistical and Data Management Center for the AIDS Clinical Trials Group

National Institutes of Health

Grant: 3UL1RR025758-04S1

Harvard Clinical and Translational Science Center (UL1)

National Institutes of Health

Grant: 5U01AI068636-03

AIDS Clinical Trials Group Network

National Institutes of Health

Grant: 5K08AI100699-04

Implications of HIV-1 Minority Variants for Virologic Failure and HIV Reservoirs

FWCI

0.00

Citation Percentile

0.2%

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/xcnw-dm02

https://doi.org/10.1371/journal.pone.0090485

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090485&type=printable

https://dx.doi.org/10.17615/xcnw-dm02

https://pubmed.ncbi.nlm.nih.gov/24603872

Fields of Study

HIV/AIDS drug development and treatmentHIV Research and TreatmentHepatitis C virus research0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

RaltegravirAntiretroviral therapyMedicineComputational biologyHuman immunodeficiency virus (HIV)BiologyVirologyViral loadAnti-HIV AgentsScienceRetrovirology and HIV immunopathogenesis610HIV InfectionsViral diseasesBiostatisticsMicrobiologyRaltegravir Potassium616Drug Resistance, ViralHumansGenome SequencingTreatment FailureStatisticsQRHIVHigh-Throughput Nucleotide SequencingHIV diagnosis and managementGenomicsAntiviralsPyrrolidinonesMutationHIV-1Infectious diseasesSequence AnalysisMathematicsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 7: 7. Clean energySDG 13: 13. Climate actionSDG 16: 16. Peace & justiceSDG 0: Zero hunger